@article{stevenson2016adalimumab,
  title={Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.},
  author={Stevenson, Matt and Archer, Rachel and Tosh, Jon and Simpson, Emma and Everson-Hock, Emma and Stevens, John and Hernandez-Alava, Monica and Paisley, Suzy and Dickinson, Kath and Scott, David and others},
  journal={Health Technology Assessment},
  volume={20},
  number={35},
  pages={1--610},
  year={2016},
  publisher={NIHR Health Technology Assessment Programme}
}

@article{stevenson2017cost,
  title={The cost-effectiveness of sequences of biological disease-modifying antirheumatic drug treatment in England for patients with rheumatoid arthritis who can tolerate methotrexate},
  author={Stevenson, Matt D and Wailoo, Allan J and Tosh, Jonathan C and Hernandez-Alava, Monica and Gibson, Laura A and Stevens, John W and Archer, Rachel J and Simpson, Emma L and Hock, Emma S and Young, Adam and others},
  journal={The Journal of Rheumatology},
  pages={jrheum--160941},
  year={2017},
  publisher={The Journal of Rheumatology}
}

@article{tosh2011sheffield,
  title={The Sheffield rheumatoid arthritis health economic model},
  author={Tosh, Jonathan and Brennan, Alan and Wailoo, Allan and Bansback, Nick},
  journal={Rheumatology},
  volume={50},
  number={suppl 4},
  pages={iv26--iv31},
  year={2011},
  publisher={Br Soc Rheumatology}
}

@article{madan2015consensus,
  title={Consensus decision models for biologics in rheumatoid and psoriatic arthritis: recommendations of a multidisciplinary working party},
  author={Madan, Jason and Ades, Tony and Barton, Pelham and Bojke, Laura and Choy, Ernest and Helliwell, Philip and Jobanputra, Paresh and Stein, Ken and Stevens, Andrew and Tosh, Jonathan and others},
  journal={Rheumatology and Therapy},
  volume={2},
  number={2},
  pages={113--125},
  year={2015},
  publisher={Springer}
}

@article{fransen2005disease,
  title={The Disease Activity Score and the EULAR response criteria},
  author={Fransen, J and Van Riel, PLCM and others},
  journal={Clinical and experimental rheumatology},
  volume={23},
  number={5},
  pages={S93},
  year={2005},
  publisher={CLINICAL AND EXPERIMENTAL RHEUMATOLOGY SAS}
}

@article{ramiro2017safety,
  title={Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis},
  author={Ramiro, Sofia and Sepriano, Alexandre and Chatzidionysiou, Katerina and Nam, Jackie L and Smolen, Josef S and van der Heijde, D{\'e}sir{\'e}e and Dougados, Maxime and van Vollenhoven, Ronald and Bijlsma, Johannes W and Burmester, Gerd R and others},
  journal={Annals of the rheumatic diseases},
  pages={annrheumdis--2016},
  year={2017},
  publisher={BMJ Publishing Group Ltd}
}

@article{wolfe2010loss,
  title={The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study},
  author={Wolfe, Frederick and Michaud, Kaleb},
  journal={Arthritis research \& therapy},
  volume={12},
  number={2},
  pages={R35},
  year={2010},
  publisher={BioMed Central}
}

@article{michaud2011treatment,
  title={Treatment and nontreatment predictors of health assessment questionnaire disability progression in rheumatoid arthritis: a longitudinal study of 18,485 patients},
  author={Michaud, Kaleb and Wallenstein, Gene and Wolfe, Frederick},
  journal={Arthritis care \& research},
  volume={63},
  number={3},
  pages={366--372},
  year={2011},
  publisher={Wiley Online Library}
}

@article{norton2013trajectories,
  title={Trajectories of functional limitation in early rheumatoid arthritis and their association with mortality},
  author={Norton, Sam and Sacker, Amanda and Dixey, Josh and Done, John and Williams, Peter and Young, Adam},
  journal={Rheumatology},
  pages={ket253},
  year={2013},
  publisher={Br Soc Rheumatology}
}

@inproceedings{norton2014health,
  title={Health Assessment Questionnaire disability progression in early rheumatoid arthritis: systematic review and analysis of two inception cohorts},
  author={Norton, Sam and Fu, Bo and Scott, David L and Deighton, Chris and Symmons, Deborah PM and Wailoo, Allan J and Tosh, Jonathan and Lunt, Mark and Davies, Rebecca and Young, Adam and others},
  booktitle={Seminars in arthritis and rheumatism},
  volume={44},
  number={2},
  pages={131--144},
  year={2014},
  organization={Elsevier}
}

@article{dias2013evidence,
  title={Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials},
  author={Dias, Sofia and Sutton, Alex J and Ades, AE and Welton, Nicky J},
  journal={Medical Decision Making},
  volume={33},
  number={5},
  pages={607--617},
  year={2013},
  publisher={Sage Publications Sage CA: Los Angeles, CA}
}

@article{singh2011adverse,
  title={Adverse effects of biologics: a network meta-analysis and Cochrane overview},
  author={Singh, Jasvinder A and Wells, George A and Christensen, Robin and Tanjong Ghogomu, Elizabeth and Maxwell, Lara J and MacDonald, John K and Filippini, Graziella and Skoetz, Nicole and Francis, Damian K and Lopes, Luciane C and others},
  journal={The Cochrane Library},
  year={2011},
  publisher={Wiley Online Library}
}

@article{alava2013relationship,
  title={The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis},
  author={Alava, M{\'o}nica Hern{\'a}ndez and Wailoo, Allan and Wolfe, Fred and Michaud, Kaleb},
  journal={Rheumatology},
  volume={52},
  number={5},
  pages={944--950},
  year={2013},
  publisher={Br Soc Rheumatology}
}

@article{oppong2013impact,
  title={The impact of using different tariffs to value EQ-5D health state descriptions: an example from a study of acute cough/lower respiratory tract infections in seven countries},
  author={Oppong, Raymond and Kaambwa, Billingsley and Nuttall, Jacqueline and Hood, Kerenza and Smith, Richard D and Coast, Joanna},
  journal={The European journal of health economics},
  volume={14},
  number={2},
  pages={197--209},
  year={2013},
  publisher={Springer}
}

@article{arias2015united,
  title={United States life tables, 2011.},
  author={Arias, Elizabeth},
  journal={National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System},
  volume={64},
  number={11},
  pages={1--62},
  year={2015}
}

@article{wolfe2003predicting,
  title={Predicting mortality in patients with rheumatoid arthritis},
  author={Wolfe, Frederick and Michaud, Kaleb and Gefeller, Olaf and Choi, Hyon K},
  journal={Arthritis \& Rheumatism},
  volume={48},
  number={6},
  pages={1530--1542},
  year={2003},
  publisher={Wiley Online Library}
}

@article{michaud2012mortality,
  title={Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis},
  author={Michaud, Kaleb and Vera-Llonch, Montserrat and Oster, Gerry},
  journal={The Journal of rheumatology},
  volume={39},
  number={1},
  pages={54--59},
  year={2012},
  publisher={The Journal of Rheumatology}
}

@article{claxton2016economic,
  title={An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis: Modeling the Cost of Treatment Strategies in the United States},
  author={Claxton, Lindsay and Jenks, Michelle and Taylor, Matthew and Wallenstein, Gene and Mendelsohn, Alan M and Bourret, Jeffrey A and Singh, Amitabh and Moynagh, Dermot and Gerber, Robert A},
  journal={Journal of managed care \& specialty pharmacy},
  volume={22},
  number={9},
  pages={1088--1102},
  year={2016},
  publisher={Academy of Managed Care Pharmacy}
}

@article{carlson2015economic,
  title={Economic evaluation of tocilizumab monotherapy compared to adalimumab monotherapy in the treatment of severe active rheumatoid arthritis},
  author={Carlson, Josh J and Ogale, Sarika and Dejonckheere, Fred and Sullivan, Sean D},
  journal={Value in Health},
  volume={18},
  number={2},
  pages={173--179},
  year={2015},
  publisher={Elsevier}
}

@article{wolfe2005household,
  title={Household income and earnings losses among 6,396 persons with rheumatoid arthritis.},
  author={Wolfe, Frederick and Michaud, Kaleb and Choi, Hyon K and Williams, Rhys},
  journal={The Journal of rheumatology},
  volume={32},
  number={10},
  pages={1875--1883},
  year={2005},
  publisher={The Journal of Rheumatology}
}

@article{guyot2012enhanced,
  title={Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves},
  author={Guyot, Patricia and Ades, AE and Ouwens, Mario JNM and Welton, Nicky J},
  journal={BMC medical research methodology},
  volume={12},
  number={1},
  pages={9},
  year={2012},
  publisher={BioMed Central}
}

@article{wailoo2006modeling,
  title={Modeling the cost effectiveness of etanercept, adalimumab and anakinra compared to infliximab in the treatment of patients with rheumatoid arthritis in the Medicare program},
  author={Wailoo, A and Brennan, A and Bansback, N and Nixon, R and Wolfe, F and Michaud, K},
  journal={Rockville, MD: Agency for Healthcare Research and Quality},
  year={2006}
}

@article{wailoo2008biologic,
  title={Biologic drugs for rheumatoid arthritis in the medicare program: a cost-effectiveness analysis},
  author={Wailoo, Allan J and Bansback, Nick and Brennan, Alan and Michaud, Kaleb and Nixon, Richard M and Wolfe, Fred},
  journal={Arthritis \& Rheumatology},
  volume={58},
  number={4},
  pages={939--946},
  year={2008},
  publisher={Wiley Online Library}
}

@article{sarzi2002correlation,
  title={Correlation of the score for subjective pain with physical disability, clinical and radiographic scores in recent onset rheumatoid arthritis},
  author={Sarzi-Puttini, Piercarlo and Fiorini, Tania and Panni, Benedetta and Turiel, Maurizio and Cazzola, Marco and Atzeni, Fabiola},
  journal={BMC musculoskeletal disorders},
  volume={3},
  number={1},
  pages={18},
  year={2002},
  publisher={BioMed Central}
}

@article{stephens2015modelling,
  title={Modelling the cost-effectiveness of combination therapy for early, rapidly progressing rheumatoid arthritis by simulating the reversible and irreversible effects of the disease},
  author={Stephens, Stephanie and Botteman, Marc F and Cifaldi, Mary A and van Hout, Ben A},
  journal={BMJ open},
  volume={5},
  number={6},
  pages={e006560},
  year={2015},
  publisher={British Medical Journal Publishing Group}
}

@techreport{icer2017tim,
     title = {Targeted Immune Modulators for Rheumatoid Arthritis: Effectiveness \& Value},
     year = {2017},
     author = {{Institute for Clinical and Economic Review}},
     month = {04}
}

@techreport{gibson2016haq,
     title = {Progression of disease in people with rheumatoid arthritis treated with non biologic therapies},
     year = {2015},
     author = {Laura Gibson and Monica Hernandez Alava and Allan Wailoo}
}

@article{anderson2012rheumatoid,
  title={Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice},
  author={Anderson, Jaclyn and Caplan, Liron and Yazdany, Jinoos and Robbins, Mark L and Neogi, Tuhina and Michaud, Kaleb and Saag, Kenneth G and O'dell, James R and Kazi, Salahuddin},
  journal={Arthritis care \& research},
  volume={64},
  number={5},
  pages={640--647},
  year={2012},
  publisher={Wiley Online Library}
}

@article{fransen2005disease,
  title={The Disease Activity Score and the EULAR response criteria},
  author={Fransen, J and Van Riel, PLCM and others},
  journal={Clinical and experimental rheumatology},
  volume={23},
  number={5},
  pages={S93},
  year={2005},
  publisher={CLINICAL AND EXPERIMENTAL RHEUMATOLOGY SAS}
}

@article{aletaha2005simplified,
  title={The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis},
  author={Aletaha, D and Smolen, J},
  journal={Clinical and experimental rheumatology},
  volume={23},
  number={5},
  pages={S100},
  year={2005},
  publisher={CLINICAL AND EXPERIMENTAL RHEUMATOLOGY SAS}
}

@article{smolen2003simplified,
  title={A simplified disease activity index for rheumatoid arthritis for use in clinical practice},
  author={Smolen, JS and Breedveld, FC and Schiff, MH and Kalden, JR and Emery, P and Eberl, G and Van Riel, PL and Tugwell, P},
  journal={Rheumatology},
  volume={42},
  number={2},
  pages={244--257},
  year={2003},
  publisher={Oxford University Press}
}

@article{prevoo1995modified,
  title={Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis},
  author={Prevoo, MLL and Van't Hof, MA and Kuper, HH and Van Leeuwen, MA and Van De Putte, LBA and Van Riel, PLCM},
  journal={Arthritis \& Rheumatology},
  volume={38},
  number={1},
  pages={44--48},
  year={1995},
  publisher={Wiley Online Library}
}

@article{singh20162015,
  title={2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis},
  author={Singh, Jasvinder A and Saag, Kenneth G and Bridges, S Louis and Akl, Elie A and Bannuru, Raveendhara R and Sullivan, Matthew C and Vaysbrot, Elizaveta and McNaughton, Christine and Osani, Mikala and Shmerling, Robert H and others},
  journal={Arthritis \& rheumatology},
  volume={68},
  number={1},
  pages={1--26},
  year={2016},
  publisher={Wiley Online Library}
}

@article{deighton2010bsr,
  title={BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy},
  author={Deighton, Chris and Hyrich, Kimme and Ding, Tina and Ledingham, Jo and Lunt, Mark and Luqmani, Raashid and Kiely, Patrick and Bukhari, Marwan and Abernethy, Rikki and Ostor, Andrew and others},
  journal={Rheumatology},
  volume={49},
  number={6},
  pages={1197--1199},
  year={2010},
  publisher={Oxford University Press}
}